KIAA1549L | KIAA1549-like | Predicted membrane proteins
| | | | | Tissue enriched |
LHFPL3 | Lipoma HMGIC fusion partner-like 3 | Predicted membrane proteins
| | | | | Tissue enriched |
MCHR2 | Melanin-concentrating hormone receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
OLFM1 | Olfactomedin 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PDYN | Prodynorphin | Disease related genes Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
TMEM132D | Transmembrane protein 132D | Predicted membrane proteins
| | | | | Tissue enriched |
AK5 | Adenylate kinase 5 | Enzymes
| | | | | Tissue enriched |
BTBD17 | BTB (POZ) domain containing 17 | Predicted secreted proteins
| | | | | Tissue enriched |
FABP7 | Fatty acid binding protein 7, brain | | | | | | Tissue enriched |
PTPN5 | Protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SV2B | Synaptic vesicle glycoprotein 2B | Predicted membrane proteins
| | | | | Tissue enriched |
TUBB2B | Tubulin, beta 2B class IIb | Disease related genes
| | | | | Tissue enriched |
BAALC | Brain and acute leukemia, cytoplasmic | | | | | | Tissue enriched |
C1QL2 | Complement component 1, q subcomponent-like 2 | Predicted secreted proteins
| | | | | Tissue enriched |
CHRNB2 | Cholinergic receptor, nicotinic, beta 2 (neuronal) | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
FAM181B | Family with sequence similarity 181, member B | | | | | | Tissue enriched |
GNG3 | Guanine nucleotide binding protein (G protein), gamma 3 | RAS pathway related proteins
| | | | | Tissue enriched |
GPR62 | G protein-coupled receptor 62 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
KCNC1 | Potassium voltage-gated channel, Shaw-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNK12 | Potassium channel, subfamily K, member 12 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
NETO1 | Neuropilin (NRP) and tolloid (TLL)-like 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PCDHA5 | Protocadherin alpha 5 | Predicted membrane proteins
| | | | | Tissue enriched |
RPH3A | Rabphilin 3A homolog (mouse) | | | | | | Tissue enriched |
SYT11 | Synaptotagmin XI | | | | | | Tissue enriched |
TMEM59L | Transmembrane protein 59-like | Predicted membrane proteins
| | | | | Tissue enriched |
TRIM9 | Tripartite motif containing 9 | Cytoskeleton related proteins
| | | | | Tissue enriched |
ACTL6B | Actin-like 6B | | | | | | Tissue enriched |
B3GAT2 | Beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
C1QL3 | Complement component 1, q subcomponent-like 3 | Predicted secreted proteins
| | | | | Tissue enriched |
CADM2 | Cell adhesion molecule 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CHN1 | Chimerin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DSCAM | Down syndrome cell adhesion molecule | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ELFN2 | Extracellular leucine-rich repeat and fibronectin type III domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
ENC1 | Ectodermal-neural cortex 1 (with BTB domain) | Cancer-related genes Cytoskeleton related proteins
| | | | | Tissue enriched |
ERC2 | ELKS/RAB6-interacting/CAST family member 2 | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enriched |
FAM131B | Family with sequence similarity 131, member B | | | | | | Tissue enriched |
HS3ST2 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 2 | Enzymes
| | | | | Tissue enriched |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNQ3 | Potassium voltage-gated channel, KQT-like subfamily, member 3 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KIF3C | Kinesin family member 3C | Plasma proteins
| | | | | Tissue enriched |
OLFM3 | Olfactomedin 3 | Predicted secreted proteins
| | | | | Tissue enriched |
PCDHGB1 | Protocadherin gamma subfamily B, 1 | Predicted membrane proteins
| | | | | Tissue enriched |
RASL10A | RAS-like, family 10, member A | | | | | | Tissue enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOX11 | SRY (sex determining region Y)-box 11 | Transcription factors
| | | | | Tissue enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
TMEM257 | Transmembrane protein 257 | Predicted membrane proteins
| | | | | Tissue enriched |
TMOD2 | Tropomodulin 2 (neuronal) | Cytoskeleton related proteins
| | | | | Tissue enriched |
VGF | VGF nerve growth factor inducible | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |